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Insurance reports, prospective epidemiologic studies and
national health surveys in the United States have repeatedly
documented a rise in systolic as well as diastolic blood
pressure with aging (1-3). Diastolic pressure rises until age
50 to 60 years, after which it tends to decline. Moreover,
the prevalence of hypertension similarly increases with ag-
ing so that hypertension affects as muchas 50% of an elderly
population by the seventh decade. Further, hypertension is
a major risk factor for coronary heart disease, congestive
heart failure, stroke, renal failure and intermittent claudi-
cation (4-6) . That the elevated pressure is a major deter-
minant of many of these complications is demonstrated by
a reduction in the incidence of these complications with
antihypertensive treatment (5-10). Indeed. rhere has been
a reduction in faral stroke of more than 40e;t, during the past
decade (9), and the recenr report of the European Working
Party on Hypertension in [he Elderly has documented a 60%
reduction in fatal myocardial infarction (/ 0).
Definitions and Prevalence
The prevalence of hypertension in a population is ob-
viously dependent on its definition . A recent report shows
that the prevalenceof hypertension (systolic pressure 2: 160
mm Hg or diastolic pressure 2 95 mm Hg, or both) in the
United States was 44% in white individuals aged 65 through
74 years and 60% in black individuals in this age range
(I I ).
The prevalence would be far higher if levels of "> 140
mm Hg systolic pressure or 2:90 mm Hg diastolic pressure.
or both. were used as the definition (Table I). Because
hypertension is exceedingly common in an aging popula-
tion, as are its complications. the necessity for well selected
antihypertensive treatment programs is of major importance.
Selection of patients for treatment. Generally accept-
able definitions of normal and abnormal blood pressure lev-
els are needed to select patients for therapy. Individuals
whose blood pressures are s; 140 mm Hg systolic and 5,:84
mrn Hg diastolic have normal blood pressure. Those who
have systolic pressures :;140 mm Hg and diastolic pressures
85 to89 mm Hghavehighnormaldiastolic pressure (12.13).
Individuals irrespective of age whose diastolic pressure is
'0 19~7 by the American College of (;mli"logy
> 89 mm Hg on three separate occasions uf blood pressure
measurement have diastolic hypertension and their blood
pressures should be controlled. The group of patients whose
systolic pressure is between 140 and 160 mrn Hg have
borderline isolated systolic hypertension (if the diastolic
pressure is < 90 mm Hg). Those whose diastolic pressure
is < 90 rnm Hg but whose systolic pressure is > 159 rnrn
Hg have isolated systolic hypertension (12.13).
Because of the high incidence and prevalence of hyper-
tension in the elderly population. blood pressures of all
elderly individuals should be rechecked on an annual basis,
even if blood pressures are initially within the normal range.
Individuals whose pressures are between 140 and 159 mill
Hg systolic should also have their pressures rechecked at
least every 6 months. Patients whose diastolic pressures are
consistently 2:90 mm Hg should be treated. The Joint Na-
tional Committee's Third Report suggesls that those whose
diastolic pressures are between 90 and 95 mm Hg might be
managed with a nonpharrnacologic treatment program be-
fore initiating drug therapy (13).
Antihypertensive drug therapy is .\'(~(e and is well toler -
ated in the elderly. In the Hypertension Detection and Fol-
lOW-Up Program (HDEP) Cooperative Group Study, anti-
hypertensive therapy had no more side effects in patients
60 to 69 years than in younger patients (14). In the Systolic
Hypertension in the Elderly Program (SHEP). adverse ef-
fects were no more frequent in the drug-treated group than
in the placebo group (15).
Blood Pressure Measurement
There are two major pitfalls in measuring blood pressure
ill the elderly . Accuracy of indirect blood pressure mea-
surements may be adversely affected by a blood pressure
cuff of inappropriate width because obesity frequently co-
exists in patients with hypertension (13). The wider blood
pressure cuffs should be used in patients whose arm girth
is abnormally large (16). More important lor the aging pop-
ulation, however, is the effect of sclerosis of the brachial
artery on cuff blood pressure measurement. The sclerotic
brachial artery resists compression by the blood pressure
cuff, and therefore the recorded pressure measurement may
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Table 1. Prevalence of Hypertension: Age 65 to 74 Years*
*Adaptedwith permissionfrom The WorkingGroup on Hypertension
in the Elderly (25).
Blood Pressure
==-160 and/or ==-95
mm Hg
73 43
48 38
60
44
45
elevated blood pressure have essential hypertension. About
10% have a secondary cause. The most important cause in
the elderly individual is atherosclerotic renal artery disease.
This diagnosis should be suspected in any elderly individual
who has had a recent onset of diastolic hypertension or who
has become resistant to a previously effective treatment
program. Moreover, the development of unexplained hy-
pokalemia should suggest a secondary form of hypertension
and either primary or secondary hyperaldosteronism (the
latter more frequently produced by renal artery disease)
(13,19-21,25). Evaluation of secondary hypertension is ad-
dressed in Reference 25.
Men
83 67
66 59
76
63
64
Blood Pressure
==-140 and/or ==-90
mm Hg
WomenMenWomen
Black (%)
White (%)
Total blacks (%)
Total whites (%)
Total (all races) (%)
be falsely elevated. This phenomenon is called pseudohy-
pertension (17). Care should be taken in patients with atrial
fibrillation to detect the first (appearance) and fifth (disap-
pearance) Korotkoff sounds by slow deflation of the cuff,
with replication and averaging of severaJ measurements (16).
Blood pressure measurement techniques for long-term
surveillance are addressed in the 1984 report of the Joint
National Committee on Detection, Evaluation, and Treat-
ment of High Blood Pressure (13). Blood pressure levels
obtained by home blood pressure measurement, if per-
formed by appropriately trained health professionals, may
augment office blood pressure measurements and help reg-
ulate dosing schedules. A report concerning the use of blood
pressure measuring devices was recently published by the
National High Blood Pressure Education Program and its
Coordinating Committee (18).
Therapy
General Measures
Recent reports have presented concise discussions of the
therapy of hypertension (specific agents, dosages, side ef-
fects and drug selection, for example) particularly in ref-
erence to the elderly individual (13,19-21,25). These re-
ports emphasize the value of nonpharmacologic means to
reduce pressure in those individuals with a diastolic pressure
between 90 and 94 mm Hg (13,25,26). Nonpharmacologic
measures may also provide the means to reduce the dosages
or number, or both, of pharmacologic agents required for
patients with higher pressures. Three major nonpharmaco-
logic approaches are emphasized: I) a sodium-restricted diet
«75 to 100 mEq daily); 2) weight reduction if appropriate;
and 3) moderation in alcohol consumption (:s2 ounces daily)
(13,26).
Pathophysiology
Comprehensive reference summaries of the pathophys-
iology of hypertension are available (19-21). The Fra-
mingham Study demonstrated that the higher the systolic as
well as diastolic pressure the greater the cardiovascular mor-
bidity and mortality; this also pertains to the prevalence of
stroke (22).
Effect of left ventricular tension on oxygen demand.
The oxygen demand of the myocardium is directly related
to the tension of the ventricular wall (23); and wall tension
is directly related to two factors, systolic pressure and the
radius of the ventricular chamber. As indicated previously,
systolic pressure increases with aging, but so does left ven-
tricular wall thickness and diameter (24). Therefore, the
borderline (140 to 160 mm Hg) or elevated (2: 160 mm Hg)
systolic pressure of the elderly moderately increases left
ventricular oxygen demand. Reduction in systolic pressure
significantly reduces wall tension and has a beneficial effect
not only for the patient's hypertension but also for coexistent
coronary artery disease.
Essential versus secondary hypertension. In general,
over 90% of patients, elderly or not, with an abnormally
Diastolic Hypertension
Reduction of diastolic pressure to <90 mm Hg is rec-
ommended, although this is qualified by advising it reduction
of at least 10 mm Hg if pretreatment diastolic pressures are
< 100 mm Hg (13,25). Antihypertensive drug therapy may
be instituted through a stepped-care program in which small
doses of a diuretic or a beta-adrenergic receptor blocking
agent may be prescribed and then increased to higher doses,
after which a second drug may be added (13). The Joint
National Committee report (13) favored a diuretic as the
first step for treating the elderly individual. Some authorities
(13,27) have suggested initiating therapy with an angioten-
sin-converting enzyme inhibitor or a calcium blocking drug
in the elderly.
Isolated Systolic Hypertension
For patients in whom only a systolic pressure elevation
is demonstrated, nonpharmacologic means may be started
initially. if blood pressure is not controlled, other agents
may be added. The Systolic Hypertension in the Elderly
Program (15) recently demonstrated that treatment with smalI
doses of a diuretic was effective in lowering systolic hy-
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pertension. At present a major multicenter study is being
conducted by the National Heart. Lung. and Blood Institute
and the National Institute on Aging to assess the efficacy
of antihypertensive therapy in reducing the cardiovascular
morbidity and mortality of isolated systolic hypertension in
the elderly.
Summary
Hypertension is a common problem with advancing age.
approaching or exceeding a 50% prevalence in the aging
population. When hlood pressure consistently exceeds 140;90
rnm Hg, il should be treated. Patients with borderline iso-
lated systolic hypertension should have their blood pressure
measured at 6 month intervals. Risk of isolated systolic
hypertension is sufficient to justify cautiously administering
drug therapy if nonpharmacologic therapy fails to bring the
systolic pressure < 160 nun Hg, even though controlled
studies have not heen completed to prove efficacy . Both
nonpharmacologic and pharmacologic therapy are recom-
mended for those with sustained pressure elevation. Adverse
effects of antihypertensivedrugs may he minimized by start-
ing with lower doses and by checking blood pressure in the
upright position.
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